Person

Rachna Khosla

SVP, Business Development, Amgen

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$2.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • AMGN
    Amgen
    SVP, Business Development
    since Sep 2021

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 13, 2026AMGNSale1,252$416.43$521K
Aug 11, 2026AMGNSale2,000$412.57$825K
Nov 12, 2025AMGNSale890$336.24$299K
Jun 5, 2025AMGNSale1,500$289.68$435K
Nov 9, 2022AMGNSale387$292.90$113K

SEC reporting-owner ID (CIK) 1881332 · all filings on EDGAR

Rachna Khosla (AMGN) | USBoard